MTOR and cancer: The acidic protein tuftelin 1 (TUFT1) is involved in mTORC1 activation by interacting with the RAB GTPase activating protein 1 (RABGAP1) and therefore may constitute a biomarker or a candidate for targeted therapy in mTOR activated, progressive cancers [28].